Correlation Between Replimune and NextCure
Can any of the company-specific risk be diversified away by investing in both Replimune and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and NextCure, you can compare the effects of market volatilities on Replimune and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and NextCure.
Diversification Opportunities for Replimune and NextCure
Excellent diversification
The 3 months correlation between Replimune and NextCure is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Replimune i.e., Replimune and NextCure go up and down completely randomly.
Pair Corralation between Replimune and NextCure
Given the investment horizon of 90 days Replimune Group is expected to generate 1.59 times more return on investment than NextCure. However, Replimune is 1.59 times more volatile than NextCure. It trades about 0.11 of its potential returns per unit of risk. NextCure is currently generating about -0.09 per unit of risk. If you would invest 1,028 in Replimune Group on September 2, 2024 and sell it today you would earn a total of 380.00 from holding Replimune Group or generate 36.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Replimune Group vs. NextCure
Performance |
Timeline |
Replimune Group |
NextCure |
Replimune and NextCure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Replimune and NextCure
The main advantage of trading using opposite Replimune and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |